Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Societal CDMO's Return On Capital Employed Overview

Benzinga Pro data, Societal CDMO (NASDAQ:SCTL) reported Q1 sales of $21.20 million. Earnings fell to a loss of $4.26 million, resulting in a 80.91% decrease from last quarter.

Benzinga

Tango Therapeutics's Return On Capital Employed Insights

Benzinga Pro data, Tango Therapeutics (NASDAQ:TNGX) reported Q1 sales of $5.76 million. Earnings fell to a loss of $25.21 million, resulting in a 14.34% decrease from last quarter.

Benzinga

RAPT Therapeutics Earnings Perspective: Return On Capital Employed

Benzinga Pro data, RAPT Therapeutics (NASDAQ:RAPT) reported Q1 sales of $641.00 thousand. Earnings fell to a loss of $20.47 million, resulting in a 14.16% decrease from last quarter.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Looking Into Priority Tech Holdings's Return On Capital Employed

Priority Tech Holdings (NASDAQ:PRTH) brought in sales totaling $153.24 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 102.36%, resulting in a loss of $333.00 thousand.

Benzinga

Summit Wireless's Return On Capital Employed Overview

Summit Wireless (NASDAQ:WISA) brought in sales totaling $566.00 thousand during Q1 according to data provided by Benzinga Pro. However, earnings decreased 27.21%, resulting in a loss of $3.90 million.

Benzinga

Arhaus's Return On Capital Employed Insights

According to Benzinga Pro, during Q1, Arhaus (NASDAQ:ARHS) earned $16.06 million, a 152.8% increase from the preceding quarter. Arhaus also posted a total of $246.30 million in sales, a 3.39% increase since Q4.

Benzinga

What 4 Analyst Ratings Have To Say About Tilray Brands

Within the last quarter, Tilray Brands (NASDAQ:TLRY) has observed the following analyst ratings:

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Where Skyworks Solutions Stands With Analysts

Skyworks Solutions (NASDAQ:SWKS) has observed the following analyst ratings within the last quarter:

Benzinga

Analyst Ratings for Liberty Braves Group

Within the last quarter, Liberty Braves Group (NASDAQ:BATRK) has observed the following analyst ratings:

Benzinga

Alibaba Ropes In Expedia Head As SCMP CEO As It Devotes Former Chief To NFT Spinoff

Alibaba Group Holding Limited's (NASDAQ:BABA) The South China Morning Post (SCMP) roped in Expedia Group, Inc's (NASDAQ:EXPE) Asian head, Catherine So, as its new CEO, Bloomberg reports. So succeeds Gary Liu, who will leave in July to oversee crypto-spinoff Artifacts Lab. The Harvard alumni So, who's also worked at Groupon, Inc (NASDAQ:GRPN), Star TV, and AOL Time Warner,…

Benzinga

Why Robinhood Markets Stock Is Sliding Today

Robinhood Markets Inc (NASDAQ: HOOD) shares are trading lower Wednesday following bearish analyst coverage from Atlantic Equities.

Benzinga

Sono Motors Partners With Logistics Provider Rhenus - Read Why

Sono Group NV (NASDAQ:SEV) has partnered with the Rhenus Group, a logistics service provider, on using smart solar technology in last-mile logistics. The cooperation aims to collect extensive solar data in real-world operations on the road to further optimize the potential of Sono Motors' solar technology for use on vans. A Rhenus…

Benzinga

Where Oatly Group Stands With Analysts

Oatly Group (NASDAQ:OTLY) has observed the following analyst ratings within the last quarter:

Benzinga

Where Cricut Stands With Analysts

Analysts have provided the following ratings for Cricut (NASDAQ:CRCT) within the last quarter:

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Kymera Therapeutics Commences Initial-Stage Oncology Trials

Kymera Therapeutics, Inc. (NASDAQ: KYMR) has recently initiated dosing of patients in separate Phase 1 clinical trials evaluating its oncology drug candidates KT-333 and KT-413.

Benzinga

The Daily Biotech Pulse: FDA Committee Backs Moderna Shot For 5-17 Years, 180 Life Sciences Stock Plunges, Pfizer's Posts Disappointing Paxlovid Data

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

What's Going On With Cepton Shares Today

Cepton, Inc (NASDAQ:CPTN), a provider of lidar-based solutions, looks to join the Russell 3000 index after the 2022 Russell indexes annual reconstitution, effective June 27, 2022. Jun Pei, Co-Founder, and CEO said, "At Cepton, our design philosophy and technology enabled us to win the largest ADAS series production award to date, and inclusion…

Benzinga

Hertz Announces New $2B Buyback: What Investors Need To Know

Shares of vehicle rental service company Hertz Global Holdings Inc (NASDAQ: HTZ) are moving higher Wednesday after the company announced a buyback.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Traders Bet On More Gains For APA Corp

Shares of APA Corp (NASDAQ: APA), the holding company for Apache, have rallied more than 60% year to date.

Benzinga

Hexo Q3 2022 Net Loss Grows Staggering 638% To CA$152.7M, Are There Profits?

HEXO Corp (NASDAQ: HEXO) (TSX:HEXO) revenue grew 101% in Q3 2022 to CA$45.57 million ($35.26 million) compared to CA$22.66 in Q3 2021.

Benzinga

Cisco And 2 Other Stocks Insiders Are Selling

US stock futures traded higher this morning on Wednesday ahead of the key interest rate decision from the Federal Reserve. Investors, meanwhile, focused on some notable insider trades.

Benzinga

10 Biggest Price Target Changes For Wednesday

Jefferies raised Tapestry, Inc. (NYSE: TPR) price target from $30 to $45. Tapestry shares rose 2.2% to close at $31.60 on Tuesday.

Benzinga

Why 180 Life Sciences Shares Are Plunging Today

180 Life Sciences Corp (NASDAQ:ATNF) received a written response from the U.K.'s regulatory agency and U.S. FDA related to questions submitted in a Type C meeting request for anti-TNF treatment, adalimumab, to treat early-stage Dupuytren's disease. Dupuytren's disease is a progressive fibrotic condition of the hand that causes the fingers to curl irreversibly…

Benzinga

4 Stocks Under $2 Insiders Are Aggressively Buying

US gold futures traded higher this morning on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or…

Benzinga

Omega Therapeutics Submits IND For Liver Cancer Candidate

Omega Therapeutics, Inc. (NASDAQ: OMGA) submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for its lead product candidate, OTX-2002, for the treatment of hepatocellular carcinoma (HCC).

1 … 450 451 452 453

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.